Iovance Biotherapeutics, Inc. (IOVA)
2.25
-0.06
(-2.60%)
USD |
NASDAQ |
Dec 09, 16:00
2.235
-0.02
(-0.67%)
Pre-Market: 09:21
Iovance Biotherapeutics Profit Margin (Quarterly): -135.3% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -316.6% |
| Talphera, Inc. | -443.6K% |
| Lantheus Holdings, Inc. | 7.23% |
| iRhythm Technologies, Inc. | -2.70% |
| Day One Biopharmaceuticals, Inc. | -49.57% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -54.43% |
| Return on Assets | -42.48% |
| Return on Invested Capital | -50.34% |
| Gross Profit Margin (Quarterly) | 29.61% |
| Operating Margin (Quarterly) | -133.1% |
| Return on Net Operating Assets | -68.80% |